A detailed history of Rothschild Investment LLC transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Rothschild Investment LLC holds 170 shares of OCUL stock, worth $1,501. This represents 0.0% of its overall portfolio holdings.

Number of Shares
170
Previous 70 142.86%
Holding current value
$1,501
Previous $479,000 208.77%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$6.45 - $9.23 $645 - $923
100 Added 142.86%
170 $1.48 Million
Q2 2024

Jul 30, 2024

BUY
$4.2 - $8.69 $294 - $608
70 New
70 $479,000
Q1 2024

Jul 31, 2024

SELL
$3.85 - $10.93 $211 - $601
-55 Reduced 78.57%
15 $137,000

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $680M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.